Papillary thyroid carcinoma (PTC) represents a heterogeneous disease with diverse clinical
outcomes highlighting a need to identify robust biomarkers with clinical relevance. We …

Although the vast majority of patients with papillary thyroid cancer (PTC) have a favorable
prognosis when conventional treatments are implemented, local recurrence and distant …

Papillary thyroid carcinoma (PTC) variants exhibit different prognosis, but critical
characteristics of PTC variants that contribute to differences in pathogenesis are not well …

Although papillary thyroid cancer (PTC) is curable with excellent survival rate, patients with
dedifferentiated PTC suffer the recurrence or death. As cancer immune escape plays a …

Papillary thyroid carcinoma (PTC) is heterogeneous and its molecular characteristics remain
elusive. We integrated transcriptomic sequencing, genomic analysis and clinicopathologic …

Purpose Increasing evidence indicates that there is a correlation between papillary thyroid
carcinoma (PTC) prognosis and the immune signature. Our goal was to construct a new …

Background: Papillary thyroid cancer (PTC) is the most common subtype of thyroid cancer,
and inflammation relates significantly to its initiation and prognosis. Systematic exploration …

Background Papillary thyroid carcinoma (PTC) follows an indolent course; however, up to
30% of patients develop recurrent disease requiring further treatment. Profiling PTC immune …

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …

Background The tumor microenvironment (TME) plays a pivotal role in cancer progression in
papillary thyroid carcinoma (PTC), yet the composition and the phenotype of cells within the …